TRACON Pharmaceuticals Inc (TCON)
1.78
-0.11
(-5.82%)
USD |
NASDAQ |
Apr 25, 16:00
1.78
0.00 (0.00%)
After-Hours: 20:00
TRACON Pharmaceuticals Cash from Investing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -0.004M |
| September 30, 2022 | -0.007M |
| June 30, 2022 | -0.002M |
| March 31, 2022 | -0.004M |
| December 31, 2021 | -0.009M |
| September 30, 2021 | -0.009M |
| June 30, 2021 | 3.974M |
| March 31, 2021 | -0.004M |
| December 31, 2020 | -4.003M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 10.00M |
| March 31, 2019 | 4.02M |
| Date | Value |
|---|---|
| December 31, 2018 | 5.054M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | -18.92M |
| March 31, 2018 | 5.00M |
| December 31, 2017 | -2.007M |
| September 30, 2017 | 2.994M |
| June 30, 2017 | -1.513M |
| March 31, 2017 | 4.20M |
| December 31, 2016 | -3.239M |
| September 30, 2016 | -3.329M |
| June 30, 2016 | 0.088M |
| March 31, 2016 | 8.553M |
| December 31, 2015 | -0.335M |
| September 30, 2015 | -10.52M |
| June 30, 2015 | -0.062M |
| March 31, 2015 | -0.002M |
| December 31, 2014 | -0.029M |
| September 30, 2014 | -0.021M |
| June 30, 2014 | -0.02M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-4.003M
Minimum
Dec 2020
10.00M
Maximum
Jun 2019
0.5227M
Average
--
Median
Sep 2019
Cash from Investing (Quarterly) Benchmarks
| BioSig Technologies Inc | -0.004M |
| Revolution Medicines Inc | -380.40M |
| Perspective Therapeutics Inc | -0.089M |
| Electromed Inc | -0.087M |
| Xtant Medical Holdings Inc | -2.313M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.522M |
| Cash from Financing (Quarterly) | 1.324M |
| Free Cash Flow | 3.676M |
| Free Cash Flow Per Share (Quarterly) | -0.2637 |
| Free Cash Flow to Equity (Quarterly) | -0.522M |
| Free Cash Flow Yield | 126.2% |